Press Release

Dysphagia Management Market to grow with a CAGR of 6.00%

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Global Dysphagia Management Market.

 

According to TechSci Research report, “Global Dysphagia Management Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Global Dysphagia Management Market has valued at USD 3.80 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 6.00% through 2028. This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market.

 Multidisciplinary care is a significant driver in the global dysphagia management market. Dysphagia, or difficulty swallowing, often requires a holistic and collaborative approach involving various healthcare professionals from different disciplines. Dysphagia can have multiple underlying causes, ranging from neurological disorders to structural abnormalities. A multidisciplinary team, including speech-language pathologists, otolaryngologists, gastroenterologists, dietitians, nurses, and occupational therapists, can collectively assess the individual's condition comprehensively. This thorough evaluation helps identify the cause, severity, and appropriate treatment plan. With input from multiple specialists, treatment plans for individuals with dysphagia can be highly customized. Speech-language pathologists can design swallowing exercises, dietitians can create modified texture diets, and medical specialists can address underlying medical issues, all working together to improve swallowing function. Speech-language pathologists play a pivotal role in dysphagia management by providing speech therapy and swallowing rehabilitation. They work with patients to strengthen swallowing muscles, improve coordination, and teach safe swallowing techniques. In cases where dysphagia is caused by structural abnormalities, tumors, or other medical conditions, otolaryngologists and gastroenterologists may perform procedures or surgeries to address the underlying issues. Collaboration with these specialists can lead to effective interventions.

 

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global Dysphagia Management Market.”

 

The prevalence of dysphagia is on the rise, particularly due to the increasing incidence of various cancers, with oral cancer being a significant contributor. Additionally, some cancer treatments can lead to swallowing difficulties as a side effect, necessitating the use of suitable dysphagia supplements to prevent further complications. People with Parkinson's disease or those who have had a stroke are more prone to experiencing dysphagia. Prolonged cigarette smoking is associated with one of the most severe consequences—dysphagia. Despite the alarming statistic of 6 million annual deaths attributed to tobacco use, the dysphagia management market is steadily expanding, largely driven by the growing occurrence of oropharyngeal cancers. Given the serious risks of choking, the management of dysphagia has become increasingly crucial for both older and younger populations.

In October 2022, Phagenesis Ltd. said that the FDA approved a De Novo application for the Phagenyx Neurostimulation System, a groundbreaking treatment that employs pharyngeal electrical stimulation to regain swallowing control in patients with severe dysphagia following stroke. The business is now planning for a focused debut in the United States. Dysphagia, which is generally characterized as a problem swallowing, is known as neurogenic dysphagia when it results from a disruption of the nervous system. An impairment to the central nervous system (CNS) brought on by a stroke or traumatic brain injury is the most frequent cause of neurogenic dysphagia. Damage to the peripheral nervous system brought on by prolonged mechanical ventilation or tracheostomy can potentially result in neurogenic dysphagia. In the worst situation, both CNS damage and protracted mechanical ventilation or tracheostomy can cause severe dysphagia.

 Innovative product development can be both a challenge and an opportunity in the global dysphagia management market. Dysphagia is not a one-size-fits-all condition. It can vary in severity and underlying causes from one individual to another. Developing products that cater to the diverse needs of this patient population can be challenging. Dysphagia management products must meet stringent safety and efficacy standards to ensure they do not pose any health risks to individuals with swallowing difficulties. Achieving regulatory compliance can be a complex and time-consuming process. Modified texture foods and thickened liquids often do not taste or look like their regular counterparts. Maintaining the taste and sensory appeal of dysphagia-friendly products is a significant challenge to ensure patient compliance. Achieving consistent and stable texture modifications in foods and liquids can be challenging for food manufacturers. Inconsistent textures can lead to problems with swallowing safely. Dysphagia-friendly products must meet specific nutritional requirements, as individuals with dysphagia are at risk of malnutrition. Balancing taste, texture, and nutritional content in these products can be difficult.

Global Dysphagia Management Market is segmented based on Product, Indication, Distribution Channel, and by region.

Based on Indication, Global Dysphagia Management Market is segmented into Oropharangeal Dysphagia, Esophageal Dypshagia. Oropharyngeal dysphagia is a medical condition characterized by difficulty in swallowing food, liquids, and saliva. It specifically refers to problems that occur in the oropharynx, which is the area at the back of the mouth and throat, including the tonsils and base of the tongue. Oropharyngeal dysphagia can affect people of all ages, from infants to the elderly, and it can be caused by various underlying medical conditions or anatomical abnormalities. Oropharyngeal dysphagia can be caused by a variety of underlying conditions, including neurological disorders (e.g., stroke, Parkinson's disease, multiple sclerosis), structural abnormalities (e.g., tumors, strictures, or masses in the throat), muscle weakness or dysfunction (e.g., myasthenia gravis, muscular dystrophy), and certain head and neck surgeries or injuries. Diagnosis of oropharyngeal dysphagia typically involves a combination of clinical assessments and instrumental tests, such as videofluoroscopy (modified barium swallow) or fiberoptic endoscopic evaluation of swallowing (FEES). These tests allow healthcare professionals to visualize the swallowing process and identify the specific problems.

Based on Region, North America dominated the Global Dysphagia Management Market. The United States has one of the highest healthcare expenditures per capita in the world. This high level of healthcare spending supports the development of advanced dysphagia management technologies, therapies, and products. Many individuals in North America have health insurance, which can cover the costs associated with dysphagia diagnosis, treatment, and therapy. This financial support encourages individuals to seek medical attention and adhere to recommended treatment plans. The presence of numerous healthcare companies, pharmaceutical firms, and medical device manufacturers in North America fosters competition in the dysphagia management market. This competition can drive innovation and improve the accessibility of dysphagia management solutions. North America has well-established regulatory bodies (e.g., the FDA in the United States) that oversee the approval and safety of dysphagia management products. A clear regulatory framework can encourage companies to invest in developing and marketing such products.

Asia-pacific region to witness fastest growth in the Global Dysphagia Management Market. The Asia-Pacific region has a rapidly aging population, like many other parts of the world. As people age, they are more prone to dysphagia, as it can be associated with age-related conditions and muscle weakness. This demographic trend leads to an increased demand for dysphagia management services and products. Many countries in the Asia-Pacific region have been investing in their healthcare infrastructure, including hospitals, clinics, and rehabilitation centers. This improved healthcare access can lead to better diagnosis and management of dysphagia, driving market growth. Awareness of dysphagia and its management has been on the rise globally, including in the Asia-Pacific region. As healthcare professionals and the public become more informed about the condition, there is greater recognition of the need for dysphagia management. Companies in the Asia-Pacific region have been innovating in the field of dysphagia management, developing specialized food products, thickening agents, and medical devices tailored to regional preferences and dietary habits. These innovations can drive market growth.

 

Some of the major companies operating in the Global Dysphagia Management Market include:

  • Eisai Co. Ltd
  • Becton, Dickinson, and Company
  • Hormel Health Labs
  • AstraZeneca Plc
  • Cipla Ltd
  • Nestle Health Science
  • Kent Precision Food Group Inc.
  • Bracco Diagnostics Inc.
  • Phagenesis Ltd
  • Cook medical Inc.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“Certain areas, particularly in North America, are projected to exert significant demand for Dysphagia Management. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the Global Dysphagia Management Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

Dysphagia Management Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product (Drug, Feeding Tubes, Nutritional solutions), By Indication (Oropharangeal Dysphagia, Esophageal Dypshagia), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Drug store, Specialty clinics), by region, and Competition evaluated the future growth potential of Global Dysphagia Management Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Dysphagia Management Market.

 

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: www.techsciresearch.com

Relevant News